EP0750630A4 - Procedes et materiaux d'identification d'inhibiteurs d'interactions moleculaires induites par les domaines sh3 - Google Patents

Procedes et materiaux d'identification d'inhibiteurs d'interactions moleculaires induites par les domaines sh3

Info

Publication number
EP0750630A4
EP0750630A4 EP95914721A EP95914721A EP0750630A4 EP 0750630 A4 EP0750630 A4 EP 0750630A4 EP 95914721 A EP95914721 A EP 95914721A EP 95914721 A EP95914721 A EP 95914721A EP 0750630 A4 EP0750630 A4 EP 0750630A4
Authority
EP
European Patent Office
Prior art keywords
domains
materials
methods
molecular interactions
identifying inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95914721A
Other languages
German (de)
English (en)
Other versions
EP0750630A1 (fr
Inventor
Richard J Rickles
Joan S Brugge
Martyn C Botfield
Mark J Zoller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ariad Pharmaceuticals Inc
Original Assignee
Ariad Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ariad Pharmaceuticals Inc filed Critical Ariad Pharmaceuticals Inc
Publication of EP0750630A1 publication Critical patent/EP0750630A1/fr
Publication of EP0750630A4 publication Critical patent/EP0750630A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/72—Fusion polypeptide containing domain for protein-protein interaction containing SH2 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
EP95914721A 1994-03-11 1995-03-13 Procedes et materiaux d'identification d'inhibiteurs d'interactions moleculaires induites par les domaines sh3 Withdrawn EP0750630A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20983594A 1994-03-11 1994-03-11
US209835 1994-03-11
US36983295A 1995-01-06 1995-01-06
US369832 1995-01-06
PCT/US1995/003208 WO1995024419A1 (fr) 1994-03-11 1995-03-13 Procedes et materiaux d'identification d'inhibiteurs d'interactions moleculaires induites par les domaines sh3

Publications (2)

Publication Number Publication Date
EP0750630A1 EP0750630A1 (fr) 1997-01-02
EP0750630A4 true EP0750630A4 (fr) 1998-01-07

Family

ID=26904553

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95914721A Withdrawn EP0750630A4 (fr) 1994-03-11 1995-03-13 Procedes et materiaux d'identification d'inhibiteurs d'interactions moleculaires induites par les domaines sh3

Country Status (3)

Country Link
EP (1) EP0750630A4 (fr)
AU (1) AU2159895A (fr)
WO (1) WO1995024419A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184205B1 (en) * 1994-07-22 2001-02-06 University Of North Carolina At Chapel Hill GRB2 SH3 binding peptides and methods of isolating and using same
WO1996003649A1 (fr) * 1994-07-22 1996-02-08 The University Of North Carolina At Chapel Hill PEPTIDES SE FIXANT AUX SH3 DE Src ET LEURS METHODES D'ISOLEMENT ET D'UTILISATION
US6303574B1 (en) 1994-07-22 2001-10-16 The University Of North Carolina At Chapel Hill Scr SH3 binding peptides and methods of isolating and using same
US5888763A (en) * 1994-12-30 1999-03-30 The Rockefeller University Peptides specific for the first Crk-SH3 domain
US6309820B1 (en) 1995-04-07 2001-10-30 University Of North Carolina At Chapel Hill Polypeptides having a functional domain of interest and methods of identifying and using same
JPH11509172A (ja) 1995-04-07 1999-08-17 サイトジェン・コーポレーション 目的の機能ドメインを有するポリペプチドおよびそれの同定および利用法
GB2311067B (en) * 1996-01-08 2000-03-29 Yamanouchi U K Ltd Proline rich peptides derived from the rasgap-associated protein P62
AU2053197A (en) * 1996-02-23 1997-09-10 Ariad Pharmaceuticals, Inc. Cell-based assay
US7279548B2 (en) 1996-04-03 2007-10-09 Cytogen Corporation Identification and isolation of novel polypeptides having WW domains and methods of using same
US5928868A (en) * 1996-04-26 1999-07-27 Massachusetts Institute Of Technology Three hybrid screening assay
US6723694B1 (en) 1997-05-21 2004-04-20 The Children's Medical Center Corp. Short peptides which selectively modulate intracellular signalling
JP2002516338A (ja) * 1998-05-21 2002-06-04 マクギル ユニバーシティー タンパク質チロシンホスファターゼｐｅｓｔのシグナルタンパク質への結合に干渉する、細胞移動及び／又はフォーカルアドヒージョンの阻害剤としての薬剤
DE60045243D1 (de) 1999-05-26 2010-12-30 Next Biomed Technologies Nbt Oy VERFAHREN UND MATERIALIEN ZUR ERZEUGUNG VON SH3 DOMäNEN MIT ANGEPASSTEN BINDUNGSEIGENSCHAFTEN
US20020002239A1 (en) * 1999-12-29 2002-01-03 Tanaka Richard D. Binding of polyamides to proteins having SH3 or WW domains
EP1432729B1 (fr) * 2001-07-02 2008-11-12 Merrion Research III Limited Plaque de peyer et/ou ligands de ciblage de cellules m
US7179784B2 (en) * 2001-07-10 2007-02-20 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
EP1539151B1 (fr) 2002-08-02 2009-03-18 Genesoft Pharmaceuticals, Inc. Composes biaryle a action anti-infectieuse
WO2004039318A2 (fr) 2002-10-25 2004-05-13 Genesoft Pharmaceuticals, Inc. Composes biaryle anti-infectieux
EP1587529A4 (fr) 2002-12-10 2009-08-12 Oscient Pharmaceuticals Corp Composes antibacteriens possedant un motif (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide)
JP4881156B2 (ja) * 2003-06-20 2012-02-22 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 脳性ナトリウム利尿ペプチドのアイソフォーム
CN101501067B (zh) 2006-08-08 2013-01-16 梅约医学教育与研究基金会 利尿和利尿钠的多肽
AU2008291682B2 (en) * 2007-08-24 2012-09-13 Mylexa Pty Limited Modulators of hypersensitivity reactions
WO2009036448A2 (fr) 2007-09-15 2009-03-19 Mayo Foundation For Medical Education And Research Agonistes des récepteurs peptidiques natriurétiques de type c
US8088890B2 (en) * 2008-09-26 2012-01-03 Fibrex Medical Research & Development Gmbh Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
CN107090028A (zh) 2011-08-30 2017-08-25 梅约医学教育与研究基金会 利钠多肽
US9611305B2 (en) 2012-01-06 2017-04-04 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
EP2752196A1 (fr) * 2013-01-03 2014-07-09 Université Bordeaux Segalen Peptides inhibiteurs nox-1 sélectifs et leurs utilisations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2054602A1 (fr) * 1991-10-31 1993-05-01 Anthony Pawson Methode de dosage d'une substance influant sur un systeme de regulation d'un ligand phosphoryle-sh2
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
CA2054602A1 (fr) * 1991-10-31 1993-05-01 Anthony Pawson Methode de dosage d'une substance influant sur un systeme de regulation d'un ligand phosphoryle-sh2

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GOUT, I. ET AL.: "Identification and functional characterization of SH3 domain-binding proteins", J. CELL BIOL., SUPPL. 0, (KEYSTONE SYMP. TRANSMEMB. SIG. TRANSDUCT., ISSN 0733-1959), vol. 18B, February 1994 (1994-02-01), pages 279, XP000652908 *
GOUT, I. ET AL.: "The GTPase dynamin binds to and is activated by a subset of SH3 domains", CELL, vol. 75, 1993, pages 25 - 36, XP000652048 *
LI, N. ET AL.: "Guanine-nucleotide-releasing factor hSos1 binds to Grb2 ...", NATURE, vol. 363, 1993, pages 85 - 88, XP002043217 *
REN, R. ET AL.: "Identification of a ten-amino acid proline.rich SH3 binding site", SCIENCE, vol. 259, 1993, pages 1157 - 1161, XP000652050 *
See also references of WO9524419A1 *

Also Published As

Publication number Publication date
WO1995024419A1 (fr) 1995-09-14
AU2159895A (en) 1995-09-25
EP0750630A1 (fr) 1997-01-02

Similar Documents

Publication Publication Date Title
EP0750630A4 (fr) Procedes et materiaux d'identification d'inhibiteurs d'interactions moleculaires induites par les domaines sh3
HUP9700602A3 (en) New inhibitors of bone-resorption and vitronectine-receptor-antagonists
HUP9901321A3 (en) Methods and compositions for determining the sequence of nucleic acid molecules
IL122186A (en) Heterocycles as inhibitors of leucotype adhesion and as vla-4-antagonists
IL128217A0 (en) Phosphatase inhibitors and methods of use thereof
ATE283851T1 (de) Inhibitoren von mikrosomalem triglycerid-transfer-protein und verfahren
DE69423793D1 (de) Vorrichtung zur magnetooptischen Aufzeichnung und Wiedergabe
DE59712475D1 (de) Verfahren und Vorrichtung zur Wiedergabe von Audiosignalen
PL323851A1 (en) Method of sorting materials, apparatus therefor and compound disk for use in such apparatus
EP1019043A4 (fr) Inhibiteurs de glycogene synthetase kinase-3 et procedes d'identification et d'utilisation de ces inhibiteurs
AU2996897A (en) Inhibitors of microsomal triglyceride transfer protein and method
AU2933197A (en) Inhibitors of microsomal triglyceride transfer protein and method
AU3395597A (en) Identification and comparison of protein-protein interactions and inhibitors thereof
EP0769065A4 (fr) Procede d'identification d'inhibiteurs d'activation de l'integrine
AUPN992596A0 (en) Magnetic detection of discontinuities in magnetic materials
PL339006A1 (en) Novel inhibitors of agrekanase and metaloproteinases for use in treating arthritis
GB9204064D0 (en) Method of identifying polymer materials
DE69213027D1 (de) Massnahmen zur verbesserung von isolierung und korrosionsschutz von rohrleitungen
AU4634896A (en) Methods of determining endogenous thrombin potential (etp) and thrombin substrates for use in said methods
FI945973A0 (fi) Menetelmät ja laite heikosti magneettisten aineideMenetelmät ja laite heikosti magneettisten aineiden erottamiseksi n erottamiseksi
DE69610097D1 (de) Vorrichtung und verfahren zur reduzierung der latenzzeit des lesefehlgriffs von cachespeichern
HUP9900408A3 (en) Inhibitors of fibrin cross-linking and/or transglutaminases
EP0960201A4 (fr) Inhibiteurs de ribonuclease mammaliens et utilisation desdits inhibiteurs
DE69822526D1 (de) Verfahren zur Konservierung von wassergefüllten Materialien
ZA9711548B (en) Ricin inhibitors and methods for use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961008

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ZOLLER, MARK J.

Inventor name: BOTFIELD, MARTYN C.

Inventor name: BRUGGE, JOAN S.

Inventor name: RICKLES, RICHARD J.

A4 Supplementary search report drawn up and despatched

Effective date: 19971124

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

17Q First examination report despatched

Effective date: 20000217

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030906